Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study

Introduction: The amine oxidase copper-containing 1 (AOC1) gene encodes for the diamine oxidase (DAO) enzyme. DAO is an enzyme that catabolizes some molecules, including histamine, and is the degradative enzyme in the polyamine catabolic pathway that is active in intestinal mucosal cells. Variants o...

Full description

Bibliographic Details
Main Authors: Gülşah Okutan, Teresa Perucho Alcalde, Eva Ruiz Casares, Bruno F. Penadés, Guerthy Melissa Sánchez Niño, Ana Terrén Lora, Sara López Oliva, Lorena Torrente Estríngana, Adriana Duelo, Ismael San Mauro Martín
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2023.1180777/full
_version_ 1797808350156554240
author Gülşah Okutan
Teresa Perucho Alcalde
Teresa Perucho Alcalde
Eva Ruiz Casares
Eva Ruiz Casares
Bruno F. Penadés
Guerthy Melissa Sánchez Niño
Ana Terrén Lora
Sara López Oliva
Lorena Torrente Estríngana
Adriana Duelo
Ismael San Mauro Martín
author_facet Gülşah Okutan
Teresa Perucho Alcalde
Teresa Perucho Alcalde
Eva Ruiz Casares
Eva Ruiz Casares
Bruno F. Penadés
Guerthy Melissa Sánchez Niño
Ana Terrén Lora
Sara López Oliva
Lorena Torrente Estríngana
Adriana Duelo
Ismael San Mauro Martín
author_sort Gülşah Okutan
collection DOAJ
description Introduction: The amine oxidase copper-containing 1 (AOC1) gene encodes for the diamine oxidase (DAO) enzyme. DAO is an enzyme that catabolizes some molecules, including histamine, and is the degradative enzyme in the polyamine catabolic pathway that is active in intestinal mucosal cells. Variants of AOC1 are associated with reduced DAO activity, resulting in accumulation of high levels of histamine and causing a wide range of neurological, gastrointestinal, and epidermal disorders, which are present in people with fibromyalgia. This study aimed to evaluate the impact of four AOC1 gene variants, namely, rs10156191, rs1049742, rs1049793, and rs2052129, on fibromyalgia symptoms measured by the Fibromyalgia Impact Questionnaire (FIQ), such as sleep disorders, atopic dermatitis, migraine, gastrointestinal (GI) disorders, allergies, and intolerances, in adult women with fibromyalgia.Methods: The sample consisted of 100 unrelated women with fibromyalgia between 33 and 60 years of age (48.48 years ±7.35), whose were diagnosed by a rheumatologist based on symptoms such as pain, stiffness, and fatigue. Single-nucleotide polymorphisms (SNPs) of AOC1 were identified using oral mucosa samples collected following a standard hygiene protocol. DNA was extracted, and gene variants of interest were analyzed using multiplex single-nucleotide primer extension (SNPE). Clinical data were collected using the FIQ and a series of variables that quantified the intensity and frequency of the symptoms.Results: The minor allele frequencies of rs10156191, rs1049742, rs1049793, and rs2052129 were 31.5, 10, 32.5, and 27%, respectively. Each variant was found to be in Hardy–Weinberg equilibrium, but partial linkage disequilibrium between AOC1 SNPs is suspected. The results show that fibromyalgia symptoms measured using the FIQ tend to increase with the number of risk alleles and that the intensity of dry skin and low stool consistency may be associated with an increase in the number of these alleles.Conclusion: This study constitutes the first step in investigating associations between fibromyalgia symptoms and candidate variants of the AOC1 gene in DAO enzyme activity. Identification of reduced DAO activity may improve the quality of life and treatment of symptoms in fibromyalgia patients.
first_indexed 2024-03-13T06:36:14Z
format Article
id doaj.art-9f54de9fe70440f68f1157aa1e33256c
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-03-13T06:36:14Z
publishDate 2023-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-9f54de9fe70440f68f1157aa1e33256c2023-06-09T04:48:58ZengFrontiers Media S.A.Frontiers in Genetics1664-80212023-06-011410.3389/fgene.2023.11807771180777Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot studyGülşah Okutan0Teresa Perucho Alcalde1Teresa Perucho Alcalde2Eva Ruiz Casares3Eva Ruiz Casares4Bruno F. Penadés5Guerthy Melissa Sánchez Niño6Ana Terrén Lora7Sara López Oliva8Lorena Torrente Estríngana9Adriana Duelo10Ismael San Mauro Martín11Research Centers in Nutrition and Health, CINUSA Group, Madrid, SpainVIVOLABS, Grupo Vivo, Madrid, SpainFaculty of Medicine, Permanent Training Center, Universidad Complutense de Madrid, Madrid, SpainVIVOLABS, Grupo Vivo, Madrid, SpainHuman Genetics and Molecular Diagnostics, Universidad San Pablo-CEU, Madrid, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainInternational Institute of DAO Deficiency, Barcelona, SpainResearch Centers in Nutrition and Health, CINUSA Group, Madrid, SpainIntroduction: The amine oxidase copper-containing 1 (AOC1) gene encodes for the diamine oxidase (DAO) enzyme. DAO is an enzyme that catabolizes some molecules, including histamine, and is the degradative enzyme in the polyamine catabolic pathway that is active in intestinal mucosal cells. Variants of AOC1 are associated with reduced DAO activity, resulting in accumulation of high levels of histamine and causing a wide range of neurological, gastrointestinal, and epidermal disorders, which are present in people with fibromyalgia. This study aimed to evaluate the impact of four AOC1 gene variants, namely, rs10156191, rs1049742, rs1049793, and rs2052129, on fibromyalgia symptoms measured by the Fibromyalgia Impact Questionnaire (FIQ), such as sleep disorders, atopic dermatitis, migraine, gastrointestinal (GI) disorders, allergies, and intolerances, in adult women with fibromyalgia.Methods: The sample consisted of 100 unrelated women with fibromyalgia between 33 and 60 years of age (48.48 years ±7.35), whose were diagnosed by a rheumatologist based on symptoms such as pain, stiffness, and fatigue. Single-nucleotide polymorphisms (SNPs) of AOC1 were identified using oral mucosa samples collected following a standard hygiene protocol. DNA was extracted, and gene variants of interest were analyzed using multiplex single-nucleotide primer extension (SNPE). Clinical data were collected using the FIQ and a series of variables that quantified the intensity and frequency of the symptoms.Results: The minor allele frequencies of rs10156191, rs1049742, rs1049793, and rs2052129 were 31.5, 10, 32.5, and 27%, respectively. Each variant was found to be in Hardy–Weinberg equilibrium, but partial linkage disequilibrium between AOC1 SNPs is suspected. The results show that fibromyalgia symptoms measured using the FIQ tend to increase with the number of risk alleles and that the intensity of dry skin and low stool consistency may be associated with an increase in the number of these alleles.Conclusion: This study constitutes the first step in investigating associations between fibromyalgia symptoms and candidate variants of the AOC1 gene in DAO enzyme activity. Identification of reduced DAO activity may improve the quality of life and treatment of symptoms in fibromyalgia patients.https://www.frontiersin.org/articles/10.3389/fgene.2023.1180777/fullAOC1 geneDAO geneDAO deficiencydiamine oxidasehistamine intolerancefibromyalgia
spellingShingle Gülşah Okutan
Teresa Perucho Alcalde
Teresa Perucho Alcalde
Eva Ruiz Casares
Eva Ruiz Casares
Bruno F. Penadés
Guerthy Melissa Sánchez Niño
Ana Terrén Lora
Sara López Oliva
Lorena Torrente Estríngana
Adriana Duelo
Ismael San Mauro Martín
Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
Frontiers in Genetics
AOC1 gene
DAO gene
DAO deficiency
diamine oxidase
histamine intolerance
fibromyalgia
title Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
title_full Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
title_fullStr Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
title_full_unstemmed Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
title_short Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study
title_sort cumulative effect of aoc1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia a pilot study
topic AOC1 gene
DAO gene
DAO deficiency
diamine oxidase
histamine intolerance
fibromyalgia
url https://www.frontiersin.org/articles/10.3389/fgene.2023.1180777/full
work_keys_str_mv AT gulsahokutan cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT teresaperuchoalcalde cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT teresaperuchoalcalde cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT evaruizcasares cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT evaruizcasares cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT brunofpenades cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT guerthymelissasancheznino cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT anaterrenlora cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT saralopezoliva cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT lorenatorrenteestringana cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT adrianaduelo cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy
AT ismaelsanmauromartin cumulativeeffectofaoc1genevariantsonsymptomsandpathologicalconditionsinadultwomenwithfibromyalgiaapilotstudy